Recombinant oncolytic virus NDV-anti-VEGFR2 enhances radiotherapy sensitivity in NSCLC by targeting VEGF signaling and impairing DNA repair

by Biotech Newsroom


  • Chen P, Liu Y, Wen Y, Zhou C. Non‐small cell lung cancer in China. Cancer Commun. 2022;42:937–70.

    Article 

    Google Scholar
     

  • Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C. Progress and prospects of early detection in lung cancer. Open Biol. 2017;7:170070.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kim B, Hong Y, Lee S, Liu P, Lim J, Lee Y, et al. Therapeutic implications for overcoming radiation resistance in cancer therapy….



  • Source link

    You may also like

    Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

    Free Magazines

    Recent Articles

    BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC